BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 11280607)

  • 1. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
    Grigg AP; Bhathal PS
    Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
    Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
    Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
    Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
    J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.
    McKay PJ; Murphy JA; Cameron S; Burnett AK; Campbell M; Tansey P; Franklin IM
    Bone Marrow Transplant; 1996 Jan; 17(1):63-6. PubMed ID: 8673057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
    de Diego C; Opazo S; Murga MJ; Martínez-Castro P
    Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients.
    Tomás JF; Pinilla I; García-Buey ML; García A; Figuera A; Gómez-García de Soria VGG ; Moreno R; Fernández-Rañada JM
    Bone Marrow Transplant; 2000 Sep; 26(6):649-55. PubMed ID: 11035372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
    Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
    Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload in allogeneic hematopoietic stem cell transplant recipients.
    Ali S; Pimentel JD; Munoz J; Shah V; McKinnon R; Divine G; Janakiraman N
    Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of "minor" genetic mutations in hereditary hemochromatosis: 2 case reports].
    Maccari S; Plancher AC
    Ann Ital Med Int; 2000; 15(3):221-5. PubMed ID: 11059064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C282Y and H63D mutations of the haemochromatosis gene in patients with iron overload.
    Jorquera F; Domínguez A; Díaz-Golpe V; Espinel J; Muñoz F; Herrera A; Fernández-Gundín MJ; Vivas S; Olcoz JL
    Rev Esp Enferm Dig; 2001 May; 93(5):293-302. PubMed ID: 11488107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Karakan T; Akyol G
    Bone Marrow Transplant; 2008 Oct; 42(7):461-7. PubMed ID: 18604240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
    Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
    Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.
    Robinson G; Narasimhan S; Weatherall M; Beasley R
    J Gastroenterol Hepatol; 2007 Jun; 22(6):852-4. PubMed ID: 17565641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
    Viveiros A; Schaefer B; Panzer M; Henninger B; Plaikner M; Kremser C; Franke A; Franzenburg S; Hoeppner MP; Stauder R; Janecke A; Tilg H; Zoller H
    Hepatology; 2021 Nov; 74(5):2424-2435. PubMed ID: 34048062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of iron status in patients with chronic hepatitis C.
    Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMT1 genetic variability is not responsible for phenotype variability in hereditary hemochromatosis.
    Kelleher T; Ryan E; Barrett S; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2004; 33(1):35-9. PubMed ID: 15223008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.